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Identity 
Location : 8q24.11 
DNA/RNA 
Description 






746 amino acids, 86.304 kDa. 
Expression 
mRNA is ubiquitously expressed (also in 




A tumour suppressor function is suggested; EXT1 is an 
endoplasmic reticulum (ER) resident type II 
transmembrane glycoprotein whose expression in cells 
alters the synthesis and display of cell surface heparan 
sulfate, and EXT1 was suggested to be involved in 
chain polymerization of heparan sulphate; an EXT1 
homologue in Drosophila melanogaster (tout-velu, Ttv) 
was demonstrated to be involved in heparan sulphate 
proteoglycan biosynthesis controlling diffusion of an 
important segment polarity protein called Hedgehog 
(Hh). 
Homology 
Human EXT2, EXTL1, EXTL2 and EXTL3, mouse 
Ext1, Drosophila tout velu. 
Mutations 
Germinal 
Germline mutations in EXT1 are causative for 
hereditary multiple exostoses, a genetically 
heterogeneous autosomal dominant disorder; mutations 
include nucleotide substitutions (54%), small deletions 
(27%) and small insertions (16%), of which the 
majority is predicted to result in a truncated or nn-
functional protein. 
Somatic 
No somatic mutations were found in 34 sporadic and 
hereditary osteochondromas and secondary peripheral 
chondrosarcomas tested. 
Implicated in 
Hereditary multiple exostoses 
Prognosis 
The main complication in hereditary multiple exostoses 
is malignant transformation of an osteochondroma 
(exostosis) into chondrosarcoma, which is estimated to 
occur in 1-5% of the HME cases. 
Cytogenetics 
Clonal aberrations were found at band 8q24.1 in 
sporadic and hereditary osteochondromas using 
cytogenetic analysis; loss of heterozygosity was almost 















Two patients with multiple osteochondromas 
demonstrated a germline mutation combined with loss
of the remaining wild type allele in three 
osteochondromas, supporting the Knudson's two hit 
model for tumour suppressor genes in osteochondroma 
development; these results indicate that in cartilaginous 
cells of the growth plate inactivation of both copies of 
the EXT1-gene is required for osteochondroma 
formation in hereditary cases. 
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